DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Non-invasive Measures of Distal Lung Disease in Asthmatics

Information source: Teva Pharmaceutical Industries
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Asthma

Intervention: QVAR (Drug); Advair (Drug); Servent Diskus (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Teva Branded Pharmaceutical Products, R&D Inc.

Official(s) and/or principal investigator(s):
Michelle Zeidler, MD, Principal Investigator, Affiliation: University of California, Los Angeles

Summary

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Clinical Details

Official title: Non-Invasive Measures of Distal Lung Disease in Asthmatics Before and After Therapy Directed at the Proximal vs. Distal Lung

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: High resolution Cat Scans

Detailed description: The study consists of 3 phases. There are 7 study visits.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- 18-65 years old

- Currently using SABA prn or a low-to-moderate persistent asthma

Exclusion Criteria:

- Tobacco use within 1 year or >= 5 pack years

Locations and Contacts

UCLA, Los Angeles, California 90095, United States
Additional Information

Starting date: September 2005
Last updated: March 19, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017